Clinical Trial Update: Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of etoposide in advanced ovarian or cervical cancer has been terminated. The study was sponsored by the Gynecologic Oncology Group.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Ovarian Cancer

Drugs mentioned

• Etoposide (Etoposide)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cervical Cancer, Ovarian Cancer | Phase 2 | Status: TERMINATED